| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Pattath Narayanan Suresh Kumar, Rohith Suresh, Vikas Meno. An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression. Indian journal of psychological medicine. vol 45. issue 1. 2023-02-13. PMID:36778613. |
vilazodone, a novel selective serotonin reuptake inhibitor and 5-ht1a partial agonist, was approved in 2011 for treatment for major depression. |
2023-02-13 |
2023-08-14 |
Not clear |
| Elizabeth A Bartlett, Francesca Zanderigo, Barbara Stanley, Tse-Hwei Choo, Hanga C Galfalvy, Spiro P Pantazatos, M Elizabeth Sublette, Jeffrey M Miller, Maria A Oquendo, J John Man. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 70. 2023-02-13. PMID:36780841. |
in vivo serotonin transporter and 1a receptor binding potential and ecological momentary assessment (ema) of stress in major depression and suicidal behavior. |
2023-02-13 |
2023-08-14 |
human |
| Ronghua Chen, Qianwen Lin, Juan Wu, Yongsen Lin, Ting Lin, Weiwei Wu, Xinyan Chen, Shufang Wu, Guiying Zeng, Xiaohui Lin, Yongxi Wu, Nan Liu, Yingchun Xiao, Hongbin Che. Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: A prospective randomized clinical trial. Journal of psychiatric research. vol 159. 2023-02-12. PMID:36774768. |
partial spearman correlation analysis showed that only plasma 5-hydroxytryptamine (5-ht) was positively correlated with hamilton depression rating scale score after bonferroni correction (r = 0.347, p < 0.001). |
2023-02-12 |
2023-08-14 |
human |
| Alyssa M West, Katherine M Holleran, Sara R Jone. Kappa Opioid Receptors Reduce Serotonin Uptake and Escitalopram Efficacy in the Mouse Substantia Nigra Pars Reticulata. International journal of molecular sciences. vol 24. issue 3. 2023-02-11. PMID:36768403. |
the serotonin and kappa opioid receptor (kor) systems are strongly implicated in disorders of negative affect, such as anxiety and depression. |
2023-02-11 |
2023-08-14 |
mouse |
| Michael P Hengartner, Martin Plöder. No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With Depression. Biological psychiatry. 2023-02-10. PMID:36764851. |
no clear evidence of reduced brain serotonin release capacity in patients with depression. |
2023-02-10 |
2023-08-14 |
Not clear |
| Eugenii A Rabiner, Claudio Agnorelli, Oliver Howes, David J Nutt, Philip J Cowen, David Erritzo. Reply to: No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With Depression. Biological psychiatry. 2023-02-10. PMID:36764850. |
reply to: no clear evidence of reduced brain serotonin release capacity in patients with depression. |
2023-02-10 |
2023-08-14 |
Not clear |
| Min-Kyung Joo, Xiaoyang Ma, Jong-Wook Yoo, Yoon-Jung Shin, Hyo-Jong Kim, Dong-Hyun Ki. Patient-derived Enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of NF-κB-involved serotonin and BDNF expression. Microbes and infection. 2023-02-09. PMID:36758891. |
patient-derived enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of nf-κb-involved serotonin and bdnf expression. |
2023-02-09 |
2023-08-14 |
mouse |
| George M Anderson, Christine M Ramsey, Kevin G Lynch, Joel Gelernter, David W Osli. Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors. Journal of affective disorders. 2023-02-08. PMID:36754092. |
baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: distribution and effects of demographic variables and serotonin reuptake inhibitors. |
2023-02-08 |
2023-08-14 |
Not clear |
| George M Anderson, Christine M Ramsey, Kevin G Lynch, Joel Gelernter, David W Osli. Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors. Journal of affective disorders. 2023-02-08. PMID:36754092. |
the objectives of the study were: (1) to examine the overall distribution of baseline platelet serotonin (5-hydroxytryptamine, 5-ht) values in patients seeking treatment for depression and to define subgroups based on the apparent presence or absence of drug exposure; (2) to assess the bioeffect of 5-ht reuptake inhibitors (sris) at the platelet 5-ht transporter; and (3) to examine the relationships of demographic variables including population (ancestry), sex, age, and season of sampling to platelet 5-ht concentration. |
2023-02-08 |
2023-08-14 |
Not clear |
| Elli Anna Kotsailidi, Catherine Gagnon, Lucy Johnson, Abdul Barmak Basir, Alexandra Tsigarid. Association of selective serotonin reuptake inhibitor use with marginal bone level changes around Osseointegrated dental implants. A retrospective study. Journal of periodontology. 2023-02-04. PMID:36738270. |
selective serotonin reuptake inhibitors (ssris) are used for the management of anxiety and depression. |
2023-02-04 |
2023-08-14 |
Not clear |
| Matej Murgaš, Jakob Unterholzner, Peter Stöhrmann, Cécile Philippe, Godber M Godbersen, Lukas Nics, Murray B Reed, Chrysoula Vraka, Thomas Vanicek, Wolfgang Wadsak, Georg S Kranz, Andreas Hahn, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger, Pia Baldinger-Melic. Effects of bilateral sequential theta-burst stimulation on 5-HT Translational psychiatry. vol 13. issue 1. 2023-02-01. PMID:36725835. |
effects of bilateral sequential theta-burst stimulation on 5-ht theta-burst stimulation (tbs) represents a brain stimulation technique effective for treatment-resistant depression (trd) as underlined by meta-analyses. |
2023-02-01 |
2023-08-14 |
Not clear |
| Carl L Faingold, Hua-Jun Fen. A unified hypothesis of SUDEP: Seizure-induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray. Epilepsia. 2023-01-30. PMID:36715572. |
a unified hypothesis of sudep: seizure-induced respiratory depression induced by adenosine may lead to sudep but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray. |
2023-01-30 |
2023-08-14 |
human |
| Carl L Faingold, Hua-Jun Fen. A unified hypothesis of SUDEP: Seizure-induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray. Epilepsia. 2023-01-30. PMID:36715572. |
a number of drugs that enhance the action of serotonin prevent postictal death in several sudep models and reduce postictal respiratory depression in pwe. |
2023-01-30 |
2023-08-14 |
human |
| Shrujna Patel, Brooke A Keating, Russell C Dal. Anti-inflammatory properties of commonly used psychiatric drugs. Frontiers in neuroscience. vol 16. 2023-01-27. PMID:36704001. |
instead, therapeutics are focused on symptoms and syndromes, largely driven by neurotransmitter hypotheses, such as serotonin or dopamine hypotheses of depression. |
2023-01-27 |
2023-08-14 |
human |
| Satyanarayana Moru, Venishetty Sunil Kumar, Shekar Kummari, Kotagiri Yugender Gou. A Disposable Screen Printed Electrodes with Hexagonal Ni(OH) Micromachines. vol 14. issue 1. 2023-01-21. PMID:36677207. |
the current work is focused on the development of a disposable, screen-printed electrochemical sensor for the depression biomarker, serotonin in the physiological ph medium (ph 7.4) with the aid of a hexagonal, ni(oh) |
2023-01-21 |
2023-08-14 |
Not clear |
| Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksso. The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry. vol 13. issue 1. 2023-01-21. PMID:36681669. |
the complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. |
2023-01-21 |
2023-08-14 |
Not clear |
| Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksso. The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry. vol 13. issue 1. 2023-01-21. PMID:36681669. |
the clinical response to selective serotonin reuptake inhibitors (ssris) in depression takes weeks to be fully developed and is still not entirely understood. |
2023-01-21 |
2023-08-14 |
Not clear |
| Shiau-Shian Huang, Yi-Ting Chen, Mei-Hsin Su, Shih-Jen Tsai, Hsi-Han Chen, Albert C Yang, Yu-Li Liu, Po-Hsiu Ku. Investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in Taiwanese Han population. The pharmacogenomics journal. 2023-01-19. PMID:36658263. |
investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in taiwanese han population. |
2023-01-19 |
2023-08-14 |
Not clear |
| David Erritzoe, Beata R Godlewska, Gaia Rizzo, Graham E Searle, Claudio Agnorelli, Yvonne Lewis, Abhishekh H Ashok, Alessandro Colasanti, Iro Boura, Chloe Farrell, Hollie Parfitt, Oliver Howes, Jan Passchier, Roger N Gunn, Marios Politis, David J Nutt, Philip J Cowen, Gitte M Knudsen, Eugenii A Rabine. Brain Serotonin Release Is Reduced in Patients With Depression: A [ Biological psychiatry. 2023-01-12. PMID:36635177. |
brain serotonin release is reduced in patients with depression: a [ the serotonin hypothesis of depression proposes that diminished serotonergic (5-ht) neurotransmission is causal in the pathophysiology of the disorder. |
2023-01-12 |
2023-08-14 |
Not clear |
| Isabella Marie Jamu, Haruko Okamot. Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR. Frontiers in global women's health. vol 3. 2023-01-09. PMID:36619589. |
5-ht gpcr-targeted drugs in the central nervous system (cns) manage psychiatric conditions, such as depression or bipolar and in the peripheral nervous system (pns) treat migraines. |
2023-01-09 |
2023-08-14 |
Not clear |